A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer
- PMID: 17996713
- DOI: 10.1016/j.molcel.2007.10.019
A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer
Abstract
Translational regulation is critical in cancer development and progression. Translation sustains tumor growth and development of a tumor vasculature, a process known as angiogenesis, which is activated by hypoxia. Here we first demonstrate that a majority of large advanced breast cancers overexpress translation regulatory protein 4E-BP1 and initiation factor eIF4G. Using model animal and cell studies, we then show that overexpressed 4E-BP1 and eIF4G orchestrate a hypoxia-activated switch from cap-dependent to cap-independent mRNA translation that promotes increased tumor angiogenesis and growth at the level of selective mRNA translation. Elevated levels of 4E-BP1 trigger hypoxia inhibition of cap-dependent mRNA translation at high-oxygen levels and, with eIF4G, increase selective translation of mRNAs containing internal ribosome entry sites (IRESs) that include key proangiogenic, hypoxia, and survival mRNAs. The switch from cap-dependent to cap-independent mRNA translation facilitates tumor angiogenesis and hypoxia responses in animal models.
Similar articles
-
Activation of a GPCR leads to eIF4G phosphorylation at the 5' cap and to IRES-dependent translation.J Mol Endocrinol. 2014 Jun;52(3):373-82. doi: 10.1530/JME-14-0009. Epub 2014 Apr 7. J Mol Endocrinol. 2014. PMID: 24711644
-
RNA aptamers to mammalian initiation factor 4G inhibit cap-dependent translation by blocking the formation of initiation factor complexes.RNA. 2006 Oct;12(10):1825-34. doi: 10.1261/rna.2169406. Epub 2006 Aug 29. RNA. 2006. PMID: 16940549 Free PMC article.
-
The pioneer translation initiation complex is functionally distinct from but structurally overlaps with the steady-state translation initiation complex.Genes Dev. 2004 Apr 1;18(7):745-54. doi: 10.1101/gad.1170204. Epub 2004 Apr 1. Genes Dev. 2004. PMID: 15059963 Free PMC article.
-
Eukaryotic translation initiation factor eIF4G2 opens novel paths for protein synthesis in development, apoptosis and cell differentiation.Cell Prolif. 2023 Mar;56(3):e13367. doi: 10.1111/cpr.13367. Epub 2022 Dec 22. Cell Prolif. 2023. PMID: 36547008 Free PMC article. Review.
-
[Molecular mechanisms of protein biosynthesis initiation--biochemical and biomedical implications of a new model of translation enhanced by the RNA hypoxia response element (rHRE)].Postepy Biochem. 2014;60(1):39-54. Postepy Biochem. 2014. PMID: 25033541 Review. Polish.
Cited by
-
Regulated in development and DNA damage 1 is necessary for hyperglycemia-induced vascular endothelial growth factor expression in the retina of diabetic rodents.J Biol Chem. 2015 Feb 6;290(6):3865-74. doi: 10.1074/jbc.M114.623058. Epub 2014 Dec 29. J Biol Chem. 2015. PMID: 25548280 Free PMC article.
-
Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.J Transl Med. 2022 Dec 3;20(1):556. doi: 10.1186/s12967-022-03776-y. J Transl Med. 2022. PMID: 36463238 Free PMC article.
-
Equol, an isoflavone metabolite, regulates cancer cell viability and protein synthesis initiation via c-Myc and eIF4G.J Biol Chem. 2015 Mar 6;290(10):6047-57. doi: 10.1074/jbc.M114.617415. Epub 2015 Jan 15. J Biol Chem. 2015. PMID: 25593313 Free PMC article.
-
Dual mTORC1/2 Inhibition as a Novel Strategy for the Resensitization and Treatment of Platinum-Resistant Ovarian Cancer.Mol Cancer Ther. 2016 Jul;15(7):1557-67. doi: 10.1158/1535-7163.MCT-15-0926. Epub 2016 May 16. Mol Cancer Ther. 2016. PMID: 27196780 Free PMC article.
-
Activation of tumor cell integrin alphavbeta3 controls angiogenesis and metastatic growth in the brain.Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10666-71. doi: 10.1073/pnas.0903035106. Epub 2009 Jun 16. Proc Natl Acad Sci U S A. 2009. PMID: 19541645 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous